Refractory major aphthous stomatitis managed with systemic immunosuppressants: a case report.
This article presents an unusual case of major recurrent aphthous stomatitis that was refractory to multiple topical and systemic immunosuppressive therapies. Ultimately, thalidomide was selected despite its well-recognized adverse potential, and was successful in producing remission of ulcers. Strict clinical protocols were followed for this therapy in collaboration with numerous medical providers. This case illustrates the ability of multiple oral health and medical providers to collaborate in the diagnosis, management, and follow-up of a patient with an oral vesiculoerosive disease.
Sarmadi
Mojgan
M
Department of Oral Medicine, Pathology, Oncology, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Ship
Jonathan A
JA
D000328:Adult; D002985:Clinical Protocols; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D010353:Patient Education as Topic; D011241:Prednisone / Q000008:administration & dosage; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D013792:Thalidomide; D011241:Prednisone